Cargando…

Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis

T helper 17 (Th17) cells are regarded as key factors in the pathogenesis of multiple sclerosis (MS). Although the involvement of certain microRNAs (miRNAs) in the development of MS has been reported, their roles in Th17 cell differentiation and MS pathogenesis remain elusive. In this study, we ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhi-Hui, Wang, Yi-Fei, He, Dan-Dan, Zhang, Xue-Mei, Zhou, Ying-Lian, Yue, Hui, Huang, Shan, Fu, Zheng, Zhang, Ling-Yu, Mao, Zhu-Qing, Li, Shuang, Zhang, Chen-Yu, Chen, Xi, Fu, Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660039/
https://www.ncbi.nlm.nih.gov/pubmed/31326963
http://dx.doi.org/10.18632/aging.102093
_version_ 1783439245115916288
author Li, Zhi-Hui
Wang, Yi-Fei
He, Dan-Dan
Zhang, Xue-Mei
Zhou, Ying-Lian
Yue, Hui
Huang, Shan
Fu, Zheng
Zhang, Ling-Yu
Mao, Zhu-Qing
Li, Shuang
Zhang, Chen-Yu
Chen, Xi
Fu, Jin
author_facet Li, Zhi-Hui
Wang, Yi-Fei
He, Dan-Dan
Zhang, Xue-Mei
Zhou, Ying-Lian
Yue, Hui
Huang, Shan
Fu, Zheng
Zhang, Ling-Yu
Mao, Zhu-Qing
Li, Shuang
Zhang, Chen-Yu
Chen, Xi
Fu, Jin
author_sort Li, Zhi-Hui
collection PubMed
description T helper 17 (Th17) cells are regarded as key factors in the pathogenesis of multiple sclerosis (MS). Although the involvement of certain microRNAs (miRNAs) in the development of MS has been reported, their roles in Th17 cell differentiation and MS pathogenesis remain elusive. In this study, we identified that let-7f-5p expression is significantly downregulated in CD4(+) T cells from MS patients and during the process of Th17 differentiation. The overexpression of let-7f-5p suppressed Th17 differentiation, whereas the knockdown of let-7f-5p expression enhanced this progress. We then explored the molecular mechanism through which let-7f-5p suppressed Th17 differentiation and identified signal transducer and activator of transcription 3 (STAT3), a pivotal transcription factor of Th17 cells, as a direct target of let-7f-5p. In contrast to the downregulated expression of let-7f-5p, STAT3 and p-STAT3 protein levels were dramatically upregulated and inversely correlated with let-7f-5p in peripheral blood CD4(+) T cells from MS patients. In conclusion, let-7f-5p functions as a potential inhibitor of Th17 differentiation in the pathogenesis of MS by targeting STAT3 and may serve as a new therapeutic target.
format Online
Article
Text
id pubmed-6660039
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Impact Journals
record_format MEDLINE/PubMed
spelling pubmed-66600392019-08-05 Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis Li, Zhi-Hui Wang, Yi-Fei He, Dan-Dan Zhang, Xue-Mei Zhou, Ying-Lian Yue, Hui Huang, Shan Fu, Zheng Zhang, Ling-Yu Mao, Zhu-Qing Li, Shuang Zhang, Chen-Yu Chen, Xi Fu, Jin Aging (Albany NY) Research Paper T helper 17 (Th17) cells are regarded as key factors in the pathogenesis of multiple sclerosis (MS). Although the involvement of certain microRNAs (miRNAs) in the development of MS has been reported, their roles in Th17 cell differentiation and MS pathogenesis remain elusive. In this study, we identified that let-7f-5p expression is significantly downregulated in CD4(+) T cells from MS patients and during the process of Th17 differentiation. The overexpression of let-7f-5p suppressed Th17 differentiation, whereas the knockdown of let-7f-5p expression enhanced this progress. We then explored the molecular mechanism through which let-7f-5p suppressed Th17 differentiation and identified signal transducer and activator of transcription 3 (STAT3), a pivotal transcription factor of Th17 cells, as a direct target of let-7f-5p. In contrast to the downregulated expression of let-7f-5p, STAT3 and p-STAT3 protein levels were dramatically upregulated and inversely correlated with let-7f-5p in peripheral blood CD4(+) T cells from MS patients. In conclusion, let-7f-5p functions as a potential inhibitor of Th17 differentiation in the pathogenesis of MS by targeting STAT3 and may serve as a new therapeutic target. Impact Journals 2019-07-15 /pmc/articles/PMC6660039/ /pubmed/31326963 http://dx.doi.org/10.18632/aging.102093 Text en Copyright © 2019 Li et al. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY) 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Li, Zhi-Hui
Wang, Yi-Fei
He, Dan-Dan
Zhang, Xue-Mei
Zhou, Ying-Lian
Yue, Hui
Huang, Shan
Fu, Zheng
Zhang, Ling-Yu
Mao, Zhu-Qing
Li, Shuang
Zhang, Chen-Yu
Chen, Xi
Fu, Jin
Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis
title Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis
title_full Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis
title_fullStr Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis
title_full_unstemmed Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis
title_short Let-7f-5p suppresses Th17 differentiation via targeting STAT3 in multiple sclerosis
title_sort let-7f-5p suppresses th17 differentiation via targeting stat3 in multiple sclerosis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660039/
https://www.ncbi.nlm.nih.gov/pubmed/31326963
http://dx.doi.org/10.18632/aging.102093
work_keys_str_mv AT lizhihui let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT wangyifei let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT hedandan let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT zhangxuemei let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT zhouyinglian let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT yuehui let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT huangshan let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT fuzheng let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT zhanglingyu let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT maozhuqing let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT lishuang let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT zhangchenyu let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT chenxi let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis
AT fujin let7f5psuppressesth17differentiationviatargetingstat3inmultiplesclerosis